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First published November 24, 2010; doi:10.1152/ajprenal.00531.2010.—It is
well-established that cyclophosphamide (CYP) can sensitize the pel-
vic afferent nerve arising from the urinary bladder and therefore
induce suprapubic pain. To test the possibility that CYP might
mediate the development of visceral hypereflexia/hyperalgesia by
facilitating spinal activity-dependent neural plasticity, we compared
the pelvic-urethra reflex activity and spinal N-methyl-D-aspartate
receptor NR2B subunit (NR2B) phosphorylation in rats treated with
vehicle solution and CYP. Compared with vehicle solution, when
accompanied by upregulation of phosphorylated NR2B expression in
the lumbosacral (L6–S2) dorsal horn, CYP increased the evoked
spikes in spinal reflex potentiation induced by repetitive stimulation (1
stimulation/1 s). Moreover, intraperitoneal pretreatments with NG-
nitro-L-arginine methyl ester and roscovitine, nitric oxide synthase
and cyclin-dependent protein kinase 5 (Cdk5) antagonists, respec-
tively, overwrote CYP-enhanced reflex potentiation and NR2B
phosphorylation. When compared with the untreated group, the
treatment with small-interfering RNA of NR2B, which decreased
the expression of NR2B expression, abolished CYP-dependent
reflex facilitation and spinal NR2B phosphorylation. These results
suggested that CYP might facilitate spinal reflex potentiation
mediated by N-methyl-D-aspartate receptors and participate in the
development of visceral hypereflexia/hyperalgesia through nitric
oxide- and Cdk5-dependent NR2B phosphorylation at the lumbo-
sacral dorsal horn.
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CHRONIC PATHOLOGICAL CONDITIONS such as inflammation or
irritation of visceral organs can induce changes in sensory
pathway properties, leading to visceral hypereflexia and/or
hyperalgesia (37). For example, because of the urotoxicity of
its metabolite acrolein, patients that receive cyclophosphamide
(CYP) as an anti-neoplasmic agent are known to develop
interstitial cystitis, characterized by hematuria (38) and supra-
pubic pain (12). In vivo animal studies have demonstrated that
intraperitoneal administration of CYP induces cystitis symp-
toms, including irritative voiding, gross hematuria, and lower
abdominal pain that resemble interstitial cystitis (33). There-
fore, CYP-induced cystitis has been used as an animal model
for bladder-related pain and inflammation (5, 33, 42).
In the lumbosacral dorsal horn, glutamatergic N-methyl-D-
aspartate receptor (NMDAR)-mediated neurotransmission has
been implicated in the processing of afferent nociceptive input
from the lower urinary tract (4). Spinal administration of
NMDAR agonists dose-dependently facilitates both visceromotor
reflexes and pressor responses to noxious pelvic stimulation (13).
Conversely, pharmacological blockage of NMDARs using selec-
tive antagonists inhibits nociceptive responses caused by visceral
irritation (43). These results suggest that spinal NMDARs
contribute to visceral nociception/hyperalgesia. Moreover,
phosphorylation of N-methyl-D-aspartate receptor NR2B
subunit (NR2B) tyrosine residues in NMDARs has been
noted as an important determinant of NMDAR-mediated
current (20), which defines the role of NMDARs in pain-
related neural plasticity (3, 17, 18, 22).
Our laboratory has recently documented that the acute
activation of nociceptive TRPV/TRPA-expressing afferent
fibers, fulfilled by instilling irritants in the uterus (23, 32)
and descending colon (22, 25, 26, 29), has the potential to
facilitate spinal reflex potentiation (SRP) (6, 41), a spinal
NMDAR-mediated form of pain-related neural plasticity
(15). However, the impact of chronic noxious stimulation/
inflammation on SRP is unclear. We set out to study the role
of chronic inflammation in pain-related neural plasticity by
investigating the impact of chronic CYP injection on SRP.
In addition, the role of NR2B in CYP-induced modification
of SRP was explored using selective pharmacological agents
and genetic knockdown. Moreover, in light of the fact that
nitric oxide (NO)-dependent PKG activation (7) and cyclin-
dependent protein kinase (Cdk)-dependent ERK phosphor-
ylation (28) are known to regulate NR2B phosphorylation
and therefore modulate NMDAR-mediated neural plasticity,
we employed pharmacological antagonists of NO and Cdk5
to explore the participation of intracellular NO and Cdk5 in
the NR2B-mediated modulation of SRP caused by CYP.
MATERIALS AND METHODS
Animal preparations. This study was reviewed and approved by the
Institutional Review Board of National Chung-Hsing University in
Taichung, Taiwan. Two hundred and forty-three adult female Sprague
Dawley rats (200–300 g) were used throughout this study. In CYP-
induced cystitis, there are 75 animals used to establish baseline reflex
activity; 33 received vehicle solution (Veh, ip bolus) and 55 received
CYP (150 mg/kg ip bolus) pretreatment 2 days before experiments. In
small-interfering (si) RNA experiments, there are each 40 rats that
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received intrathecal negative control (siVeh) or siRNA of NR2B
(siNR2B) injection 2 days before experiments.
Reflex activity recordings. On the day of experiment, animals
were anesthetized (1.2 g/kg ip urethrane), and a catheter was
inserted through a slit made at the atlanto-occipital membrane to
the lumbosacral spinal cord (L6–S2). Wire electromyogram elec-
trodes were placed intra-abdominally in the external urethra
sphincter to pick up external urethra sphincter electromyogram
activity. The left pelvic nerve was carefully dissected and tran-
sected. The central stump of the transected nerve was then mounted
on a pair of electrodes for stimulation. Two paradigms used were
test stimulation (TS, 1 stimulation/30 s, lasting for 30 min) for
evoking baseline reflex activity and repetitive stimulation (RS, 1
stimulation/1 s, lasting for 30 min) for inducing reflex potentiation.
Square wave pulses with a constant intensity causing a single
action potential under TS were used throughout each experiment.
Intrathecal agents were injected either 5 min following or 1 min
before stimulation started.
Drug applications. Drugs used in this study were as follows: CYP,
an anti-neoplasmic agent (150 mg/kg ip, 2 days before experiments),
4-hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperi-
dine (Co-101244, a selective NR2B antagonist, 100 nM, 10 l it),
NG-nitro-L-arginine-methyl ester (L-NAME), a NO synthetase inhib-
itor (100 M, 10 l it and 0.2 ml 2 times/day ip), roscovitine (ROS,
a Cdk5 inhibitor, 100 nM, 10 l it and 0.2 ml 2 times/day ip),
protoporphyrin IX [PPIX; a soluble guanylate cyclase (sGC) acti-
vator, 100 M, 10 l it], and N-methyl-D-aspartate (NMDA, a
selective glutamate NMDA receptor agonist, 10 M, 10 l it).
Drugs were dissolved in artificial cerebrospinal fluid or DMSO and
applied in a final DMSO concentration of 1%. A solution of
identical volume to the tested agents was dispensed to serve as the
vehicle.
Western blotting. After the experimental procedures were finished,
animals were decapitated, and the dorsal half of the left spinal cord
segments from L6–S2 was dissected. Protein samples (20 g) were
separated on SDS-PAGE (8 and 12%) and transferred to a nitrocel-
lulose membrane. Membranes were blocked in 5% nonfat milk and
probed with antibodies against phosphorylated NR2B (pNR2B,
1:1,000), total NR2B (tNR2B, 1:1,000), and -actin (1:5,000). The
blots were incubated with horseradish peroxidase-conjugated anti-
body (1:2,000) for 1 h at room temperature and visualized with
enhanced chemiluminescence solution (5 min) followed by film ex-
posure (2 min). Densitometric analysis of the WB membranes was
done with Science Lab 2003 (Fuji).
siRNA of NMDA receptor NR2B subunit. The protocol for siRNA of
the NMDA NR2B subunit was adapted from our previous study (27). The
19 nucleotide duplex and 2 unpaired nucleotide overhangs of the 3=-end
were as follows: negative control, 5=-UUCUCCGAACGUGU-
CACGUTT-3= and 3=-ACGUGACACGUUCGGAGAATT-5=; NR2B,
5=-AGCUCGUUCCCAAAAGAGCTT-3= and 3=-UUUCGAG-
CAAGGGUUUUCUTT-5=.
Chemically synthetic double-strand RNA against the negative con-
trol and the NR2B receptor were synthesized by MDBio (Taipei,
Taiwan). Specific or nonspecific siRNAs (5 g) were complexed with
0.45% of 100 mM PEI. RNA-polymer complexes were allowed 10
min to form at room temperature before the injection. Five to seven
microliters of the final solution were intrathecally injected to the
L6–S2 spinal cord of adult rats one time a day for 5 days. Animals
were allowed 2 days to recover and then were used for experiments.
Data analysis. The electromyogram activity was recorded using a
sampling rate of 20,000 Hz with a conventional band-pass filter
setting (30–3,000 Hz). The number of spikes was computed as the
mean from the last three stimulations. Comparisons across different
stimulation paradigms as well as all drug- and vehicle-treated groups
were determined using one-way, repeated-measures ANOVA, fol-
lowed by a post hoc test (SigmaStat 2.0; Systa Software, San Jose,
CA). In all cases, a difference of P  0.05 was considered as a
statistically significant difference.
RESULTS
CYP facilitated reflex potentiation and NR2B phosphorylation. To
investigate the impact of CYP on SRP, we intraperitoneally
injected Veh or CYP in animals and then evoked reflex activity
2 days later using TS (1 stimulation/30 s) and RS (1 stimula-
tion/1 s). Because TS evoked baseline reflex activity with
single action potentials (Veh TS and CYP TS; Fig. 1, A and
B), RS-induced SRP in both the Veh and CYP groups (Veh  RS
and CYP  RS, respectively) was characterized by a progres-
sive increase in firing that peaked at 100 s following stimu-
lation onset and plateaued until the end of stimulation . More-
over, CYP facilitated RS-induced SRP by further increasing
spike count when compared with the Veh group (P  0.01 vs.
Veh  RS, n  7; Fig. 1, B and C). Intrathecal administration
of Co-101244, a selective NR2B antagonist, at 1 min before
stimulation (Veh  RS  Co and CYP  RS  Co; Fig. 1, A
and C) prevented RS-induced SRP (P  0.01 vs. Veh  RS, n 
7) and partially reversed CYP-dependent facilitation by de-
creasing the evoked spike (CYP Co RS, P 0.01 vs. Veh
RS Co, n  7). The involvement of NR2B in CYP-dependent
SRP facilitation was then investigated using Western blotting
analysis. Immunoblotting showed that, compared with TS (Veh
TS and CYP  TS; Fig. 1D), pNR2B expression in the lumbo-
sacral dorsal horn was significantly increased by RS in both Veh
and CYP treatment (Veh  RS and CYP  RS, P  0.01 vs.
Veh TS, n 4), although the amounts of the tNR2B-to--actin
ratio under various treatments exhibited no statistical differ-
ence (P  0.05, n  4). In addition, with the Veh  RS
group, pNR2B expression but not the tNR2B-to--actin
ratio was significantly increased in CYP  RS animals (P 
0.05 vs. Veh  RS, n  4).
Cdk5 and NO involvement in RS-induced reflex potentiation
and NR2B phosphorylation. We next examined the involve-
ment of NO and Cdk5 in RS-induced SRP by antagonizing
each pharmacologically. We found that, compared with ani-
mals that received TS and RS, respectively, intrathecal appli-
cation of L-NAME and ROS, selective nitric oxide synthase
(NOS) and Cdk5 inhibitors, respectively, at 5 min after the start
of stimulation failed to affect TS-evoked baseline reflex activ-
ity (TS  L-NAME and TS  ROS, P  0.05 vs. TS, n  7;
Fig. 2A) and RS-induced SRP (RS L-NAME and RS ROS,
P  0.05 vs. RS, n  7; Fig. 2, A and D). In contrast,
pretreatment with L-NAME and ROS at 1 min before stimula-
tion attenuated RS-induced SRP by decreasing the mean spike
count (L-NAME  RS and ROS  RS, P  0.01 vs. RS, n 
7; Fig. 2, B and D) while exhibiting no effects on TS-evoked
baseline reflex activity (L-NAME  TS and ROS  TS, P 
0.05 vs. TS, n  7; Fig. 2, B and C). Moreover, pretreatment
with L-NAME and ROS (L-NAMA  RS and ROS  RS,
respectively; Fig. 2E) significantly reduced RS-induced phos-
phorylation of NR2B in the lumbosacral dorsal horn without
affecting the tNR2B-to--actin ratio compared with animals
that received RS only (P  0.05 vs. RS, n  4), whereas
posttreatment application had no effect (data not shown). We
next tested the involvement of NO-dependent sGC activation
in RS-induced SRP through intrathecal administration of PPIX,
a sGC activator, after RS-induced SRP was attenuated by
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L-NAME pretreatment. Electrophysiological tracings show that
intrathecal PPIX reversed L-NAME-elicited SRP attenuation
(L-NAME  RS  PPIX, P  0.01 vs. L-NAME  RS, n 
7; Fig. 2, B and D). On the other hand, Cdk-dependent NR2B
activation was also studied using a selective NMDAR agonist.
We observed that intrathecal NMDA also reversed the ROS-
dependent attenuation of RS-induced SRP (ROS  RS 
NMDA, P  0.01 vs. ROS  RS, n  7).
Roles of NO and Cdk5 in CYP-dependent facilitation of
reflex potentiation. The involvement of NO and Cdk5 in
NR2B-mediated SRP facilitation caused by CYP was then
elucidated by daily intraperitoneal injection of L-NAME and
ROS in CYP-treated animals. We found that, compared with
animals receiving saline injection, intraperitoneal pretreat-
ments of L-NAME and ROS did not affect TS-evoked baseline
reflex activity and RS-induced SRP (data not shown). On the
other hand, compared with vehicle solution [Fig. 3A (Veh) and
Fig. 3D (Veh  RS)], CYP facilitated RS-induced SRP (CYP 
RS, P  0.05 vs. Veh  RS; Fig. 3, B and D) and upregulated
pNR2B expression without affecting the tNR2B-to--actin
ratio in the lumbosacral dorsal horn (P  0.01 vs. Veh; Fig.
3A). Peritoneal pretreatments of L-NAME and ROS, while
exhibiting no effects on TS-evoked baseline reflex activity
(L-NAME  CYP  TS and ROS  CYP  TS, P  0.05 vs.
CYP TS, n 7; Fig. 3, B and C), prevented CYP-dependent
reflex facilitation (L-NAME CYP RS and ROS CYP
RS, P  0.01 vs. CYP  RS, n  7; Fig. 3, B and D) and
NR2B phosphorylation (L-NAME  CYP and ROS  CYP,
P  0.01 for CYP, n  4; Fig. 3A).
siNR2B prevention of CYP-dependent facilitation and NR2B
phosphorylation. We next knocked down NR2B expression in
the lumbosacral spinal cord by daily intrathecal injection of
mis-sense (siVeh) or NR2B siRNA (siNR2B) for 5 days.
Compared with the siVeh group, tNR2B protein expression in
siNR2B animals was significantly reduced compared with
-actin (tNR2B, P  0.01 vs. siVeh, n  4; Fig. 4A), indicat-
ing that this treatment indeed knocked down spinal NR2B
expression. In the siVeh group (Fig. 4B), CYP administration
Fig. 1. Cyclophosphamide (CYP) facilitated repetitive stimulation (RS)-induced reflex potentiation and upregulatedN-methyl-D-aspartate receptor NR2B subunit
(NR2B) phosphorylation in the lumbosacral (L6–S2) dorsal horn. A: tracings showed increased external urethra sphincter electromyogram (EUSE) activity by
electric shocks. Single pulses of test simulation (TS, 1 stimulation/30 s) evoked baseline reflex activity with single action potentials in rats treated with vehicle
solution (Veh  TS) and CYP (CYP  TS). The reflex potentiation induced by RS (1 stimulation/1 s) was characterized by an increasing firing in both groups
(Veh  RS and CYP  RS) that was antagonized by intrathecal Co-101244 administrations at 1 min before stimulation (Veh  Co  RS and CYP  Co 
RS). Ticks at the bottom of the tracing indicate the shocks. B: summary data showed the mean spike count of TS-evoked baseline reflex and RS-induced reflex
potentiation in rats treated with vehicle solution (Veh TS and Veh RS) and CYP (CYP TS and CYP RS). C: also shown were the average spike counts from
the last 3 shocks of stimulation in vehicle solution- and CYP-treated animals without (Veh  RS and CYP  RS) and with (Veh  Co  RS and CYP  Co  RS)
intrathecal Co-101244 administration (n 7). D: compared with TS (Veh TS and CYP TS), RS significantly increased phosphorylated NR2B (pNR2B) expression
in both animals treated with vehicle solution (Veh  RS) and CYP (CYP  RS), despite no statistically significant between-group difference in the level of the total
NR2B (tNR2B)-to--actin ratio (P  0.05, n  4). In addition, compared with the Veh  RS group, pNR2B but not the tNR2B-to--actin ratio was
significantly increased in CYP  RS animals. B and C: **P  0.01 vs. Veh  RS. ##P  0.01 vs. Veh  RS  Co. D: **P  0.01 vs. Veh  TS. #P 
0.05 vs. Veh  RS (n  4).
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statistically enhanced NR2B phosphorylation (CYP  RS,
P  0.05 vs. RS) compared with animals that received RS
only. In animals of the siNR2B group treated with only RS,
NR2B phosphorylation was significantly lower than that in
the siVeh group (RS in siNR2B, P  0.01 vs. RS in siVeh).
In the siNR2B group, there was also a statistically signifi-
cant decrease in NR2B phosphorylation in CYP-treated
animals compared with those in the siVeh group (CYP  RS
in siNR2B, P  0.05 vs. CYP  RS in siVeh). On the other
hand, siNR2B attenuated the RS-induced SRP (siNR2B,
P  0.01 vs. siVeh, n  7; Fig. 5, A and C) compared with
siVeh. Nevertheless, these treatments failed to affect the
baseline reflex activity evoked by the TS (Fig. 5, A and B).
Moreover, compared with siVeh (siVeh  CYP), siNR2B
significantly overwrote the CYP-dependent facilitation of
SRP (siNR2B  CYP, P  0.01 vs. siVeh  CYP, n  7;
Fig. 5, A and C).
DISCUSSION
Interstitial cystitis is a chronic inflammatory condition of the
urinary bladder that affects an estimated one million people in
the United States. Administration of CYP, which is an anti-
neoplasmic agent metabolized by the liver to produce the
bladder irritant acrolein, is known to induce cystitis in rodents
and humans (14). We injected CYP intraperitoneally to de-
velop mild but chronic bladder inflammation to explore its
possible effects on SRP modulation. Compared with vehicle
solution injection, CYP administration facilitated SRP. This
finding supports the notion that CYP administration induces
Fig. 2. NOS and cyclin-dependent protein
kinase 5 (Cdk5) participated in the reflex
potentiation induced by RS. A: tracings show
increased EUSE activity by electric shocks.
In both animals receiving it NG-nitro-L-argi-
nine methyl ester (L-NAME) and roscovitine
(ROS), administered at 5 min following the
start of stimulation, single pulses of TS
were used to evoke baseline reflex activity
with single action potentials (TS  L-
NAME and TS  ROS), whereas RS was
used to induce reflex potentiation. B: al-
though the TS-evoked baseline reflex ac-
tivity was not affected (L-NAME  TS
and ROS  TS), the RS-induced reflex
potentiation was antagonized by L-NAME
and ROS injections 1 min before stimula-
tion (L-NAME  RS and ROS  RS).
Intrathecal protoporphyrin IX (PPIX) and
N-methyl-D-aspartate (NMDA) overwrote the
antagonism caused by L-NAME (L-NAME 
RS  PPIX) and ROS (ROS  RS 
NMDA), respectively. Ticks at the bootom of
the tracing indicate the shocks. C: mean spike
count averaged from the last 3 shocks of TS in
animals receiving vehicle solution (TS), pre-
treated with L-NAME (L-NAME  TS) and
with pretreated ROS (ROS  TS). D: averaged
spike count evoked by RS in animals receiving
vehicle solution (RS), L-NAME (RS 
L-NAME), and ROS (RS  ROS) at 5 min
following the start of stimulation as well as
pretreated with L-NAME and ROS 1 min be-
fore stimulation without (L-NAME  RS and
ROS  RS) and with (L-NAME  RS 
PPIX) PPIX or NMDA (ROS  RS 
NMDA, n  7). E: in naïve animals, RS
significantly increased phosphorylated NR2B
(pNR2B) expression but not the tNR2B-to--
actin ratio in the lumbosacral (L6–S2) dorsal
horn compared with TS. Pretreatments of
L-NAME and ROS both overwrote the RS-
induced pNR2B expression (L-NAME 
RS and ROS  RS) despite the tNR2B-to-
-actin ratio exhibiting no between-group
statistical significance. B and D: **P 
0.01 vs. RS. E: *P  0.05 vs. TS. #P 
0.05 vs. RS. ##P  0.01 vs. L-NAME 
RS and vs. ROS  RS.
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visceral pain in the lower urinary tract (5). Because SRP has
been known to serve as a form of neural plasticity that relates
to pelvic visceral pain (24, 27, 30), our results prove an
extended role of CYP-induced inflammation in hypereflexia/
hyperalgesia development following bladder inflammation.
Glutamatergic NMDARs are known to underlie nocicep-
tion at the spinal cord level (2). Among the NMDAR NR1–3
subunits, the NR2 subunit is of great interest, since it is
essential for calcium gating and thus defines the electro-
physiological properties of the NMDAR (22). In addition,
there are four genes that encode NR2 subunits (NR2A-D),
and studies have revealed that NR2B-containing NMDARs
play crucial roles in activity-dependent neural plasticity
induction (3, 17, 18) because NR2B phosphorylation has
been described as an important determinant for NMDAR-
mediated current (20). In the present study, chronic CYP
administration facilitated SRP and simultaneously enhanced
spinal NR2B phosphorylation. Genetic knockdown of NR2B
expression using specific siRNA attenuated CYP-induced
facilitation and NR2B phosphorylation. These findings
agree well with studies showing that, in rats with an intact
spinal cord, administration of NMDAR antagonists strongly
decreases spinal c-Fos expression caused by bladder irrita-
tion (4) and noxious colorectal distension (43), suggesting
that NMDARs are probably involved in visceral nociception
resulting from CYP-induced cystitis in rats. Moreover, to-
Fig. 3. NOS and Cdk5 participated in CYP-
dependent facilitation of reflex potentiation.
A: compared with vehicle solution (Veh),
CYP significantly increased pNR2B expression
without affecting the tNR2B-to--actin ratio in
the lumbosacral (L6–S2) dorsal horn (CYP). In-
traperitoneal pretreatments of L-NAME and ROS
both overwrote the RS-induced pNR2B expres-
sion (L-NAMERS and ROSRS) despite no
statistically significant between-group difference
in the levels of the tNR2B-to--actin ratio. B:
tracings show the increased EUSE activity by
electric shocks. Compared with animals receiv-
ing CYP only (CYP  RS), ip pretreatments of
L-NAME (L-NAME  CYP  RS) and ROS
(ROS  CYP  RS) both antagonized CYP-
dependent facilitation of reflex potentiation.
However, these agents exhibited no effect on
the TS-evoked baseline reflex activity (L-
NAME  CYP  TS and ROS  CYP 
TS). C: no statistical significance was revealed
in the mean spike count evoked by the TS
between animals treated with vehicle solution
(Veh  TS) and CYP (CYP  TS) as well as
those treated with CYP plus L-NAME (L-
NAME  CYP  TS) or ROS (ROS  CYP
 TS). D: compared with the vehicle solution-
treated group (Veh  RS), CYP statistically
increased the mean spike count evoked by RS
(CYP  RS) that was overwrote by it L-
NAME (L-NAME  CYP  RS) and ROS
(ROS  CYP  RS) injections. B and
D: **P 0.05 vs. Veh RS. ##P 0.01 vs.
CYP  RS (n  7). A: **P  0.01 vs. Veh.
##P  0.01 for CYP (n  4).
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gether with the results showing that NR2B phosphorylation
caused by nerve injury-induced neuropathic pain is pre-
vented by NR2B knockout (1) and knockdown (39), our data
suggest that NR2B phosphorylation at the dorsal horn is
essential for neuropathic pain maintenance and/or hyperal-
gesia.
Our previous work has shown that acute irritation of
TRPV1-expressing afferent fibers coming from the descending
colon may activate spinal Cdk5 activity, which induces subse-
quent NR2B phosphorylation, resulting in cross-organ SRP
sensitization. In the current study, administration of ROS, a
Cdk5 inhibitor, attenuated CYP-induced SRP facilitation and
pNR2B expression, suggesting that Cdk5-dependent NR2B
phosphorylation is involved in CYP-induced SRP facilitation.
On the other hand, NO-dependent guanine cyclase activation
has also been implicated in SRP (7). In the present study,
pharmacological blockage of NOS using a selective inhibitor,
L-NAME, also attenuated CYP-induced SRP facilitation and
NR2B phosphorylation, suggesting a role for NO in NR2B-
dependent SRP facilitation caused by CYP. This finding is in
line with the idea that spinal NO plays roles in the modulation
of pain-related central sensitization (10). To our knowledge, no
studies have shown interaction between cascades depending on
NO and Cdk5 in activity-dependent neural plasticity develop-
ment. We suspect that CYP might activate different intracel-
lular pathways to induce NR2B phosphorylation, mediating
subsequent SRP facilitation. Studies investigating CYP-in-
duced cystitis have shown multiple pathological changes in the
lower urinary tract. For example, in vivo histological modifi-
cations have been documented (40). Considerable secondary
neurological responses, including changes in neurochemical
(21, 33–35) and electrophysiological properties (42), have also
been noted. Yoshimura and de Groat also demonstrated that, in
primary sensory fibers coming from the urinary bladder, the
initial stimulating effects of CYP are mediated by the release of
inflammatory mediators such as prostaglandin, serotonin, his-
tamine, ATP, and nerve growth factor to afferent terminals.
CYP could also produce delayed effects that alter ion channel
properties in bladder afferent neurons (42).
In this study, we pharmacologically antagonized NOS and
Cdk5 using acute intrathecal injections when we tested their
roles in the RS-induced reflex potentiation, whereas daily
intraperitoneal administrations were used when we explored
their participation in CYP-dependent facilitation. Although
these experiments shed light on the involvement of NOS and
Cdk5 in different conditions, further studies are required to
elucidate the proper doses of these agents administered through
different routes that will yield comparable bioavailability.
Moreover, studies investigating leukemic cell apoptosis (36)
and macrophage NO production (9) have demonstrated that, in
addition to Cdk5, ROS inhibits Cdk1, Cdk2, and Cdk7 as well.
In macrophages, both Cdk5 and Cdk7 were shown to inhibit
lipopolysaccharide-induced NO production by suppressing the
nuclear factor-B (NF-B) family (9). Previous work has
Fig. 4. Small-interfering (si) RNA of NR2B
blocked CYP-dependent NR2B phosphorylation.
A: compared with vehicle control (siVeh), siRNA
of NR2B significantly decreased the expression of
NR2B in the lumbosacral (L6–S2) dorsal horn
(siNR2B) compared with -actin. B: the CYP-
dependent pNR2B expression was attenuated
in siNR2B compared with siVeh animals. In
the vehicle control group (siVeh), CYP re-
sulted in a statistically significant increase
in NR2B phosphorylation (CYP  RS)
compared with animals receiving only RS.
siNR2B significantly decreased NR2B
phosphorylation in animals receiving only
RS (in siNR2B) compared with siVeh.
There was a statistically remarkable de-
crease in the NR2B phosphorylation caused
by CYP in the siNR2B group (CYP  RS in
siNR2B) compared with the vehicle control
group (CYP  RS in siVeh). A: **P  0.01
vs. siVeh. B: *P  0.05 vs. RS. **P  0.01
vs. RS in siVeh. ##P  0.05 vs. CYP  RS
in siVeh.
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demonstrated that the CaMKII-dependent NO pathway is in-
volved in the RS-induced pelvic-urethra reflex potentiation (7),
and our unpublished data showed IKK	/-dependent NF-B
activation participated in a reflex potentiation. The possibility
that whether or not other Cdks, in addition to Cdk5, might have
been involved in the induction of SRP is an interesting question
to be investigated further. Finally, because ROS has been
reported to regulate calcium channel activity (8), whether the
ROS could modulate the intracellular calcium signaling to play
roles in the SRP, a calcium-dependent form of neural plasticity
(7), should be taken into consideration.
The current study notes that, despite a lack of statistical
significance in the relationship between the spike counts for
TS-evoked baseline reflex activity for Veh and CYP-treated
animals, the expression of pNR2B in CYP-treated rats was
significantly higher than that for Veh. Although the detailed
mechanism for this phenomenon remains unclear, one cause
may be the fact that we used single pulses with an intensity that
evoked a single action potential (TS-evoked baseline reflex
activity) to standardize reflex activity. Although neural excit-
ability in CYP-treated animals enhanced pNR2B expression
upregulation in the dorsal horn, the spike count evoked by the
TS would not reflect this change, since the threshold intensity
could be reduced. This proposal was supported by the fact that
the mean threshold intensity for TS to evoke the baseline reflex
activity in CYP-treated animals (2.4 
 0.8 mA) was statisti-
cally lower than that for the Veh group (4.8 
 1.4 mA).
However, further experiments are needed to understand the
exact causes for such phenomenon and whether it may limit the
applicability of SRP to serve as a biological index for inves-
tigation into visceral pain in the pelvic region.
ACKNOWLEDGMENTS
This research was supported by the National Science Council of Taiwan
NSC 97-2320-B-040-008-MY3 and 98-2320-B-040-006-MY3 to T.-B. Lin
and NSC 99-2320-B-039-036 to H.-Y. Peng as well as by the China Medical
University CMU99-S-19 and CMU99-lab to T.-B. Lin and DMR-100-160 to
H.-Y. Peng.
DISCLOSURES
No conflicts of interest are declared by the authors.
Fig. 5. siRNA of NR2B blocked CYP-dependent facilitation of
reflex potentiation.A: tracings show increased EUSE activity by
electric shocks. TS evoked baseline reflex activity with single
action potentials in both animals receiving vehicle control
(siVeh) and siRNA NR2B (siNR2B), whereas the reflex poten-
tiation induced by RS was statistically decreased in siNR2B
compared with vehicle control. CYP facilitated RS-induced
reflex potentiation in the siVeh group but not in the siNR2B
group. B: no statistical significance was found in the mean spike
count evoked by the TS between siVeh and siNR2B and siVeh 
CYP and siNR2B CYP groups. C: CYP caused a statistically
significant increase in the mean spike count in animals receiv-
ing vehicle solution (siVeh  CYP) but not in those receiving
siNR2B (siNR2B  CYP). C: **P  0.01 vs. siVeh. ##P 
0.01 vs. siVeh  CYP.
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